Such classification results obtained from the proposed approach not only indicate RhoB protein is a potential prognosis biomarker of rectal cancer, but are also helpful for clinical decision-making if a patient with rectal cancer should be recommended for post-operative radiotherapy to reduce local recurrence or other alternative treatments, depending on the predicted survival of the patient. The gene discussed is RHOB; the disease is rectal cancer.